Form 4: CVS Health Director Roger Farah Reports Share Credit Acquisition

Director Roger Farah reports acquisition of share credits and deferred stock compensation in CVS Health Corp.

Summary

• Roger N. Farah, a director of CVS Health Corp, reported changes in beneficial ownership.
• On May 16, 2024, Farah acquired share credits for deferral of a semi-annual retainer under the 2017 Incentive Compensation Plan, totaling 5,302.5035 share credits.
• These share credits were issued at a price of $57.52 per share.
• Farah also holds 35,561.3323 shares of common stock directly.
• The total amount of common stock beneficially owned following the reported transactions is 4,124.4534 shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard compensation practices and alignment of director interests with the company's performance.

Positives

• The acquisition of share credits indicates continued alignment of the director's interests with the company's performance.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Comparison to Industry Standards

• Director compensation structures, including share credits and deferred stock, are common across publicly traded companies to incentivize long-term value creation.
• Companies like Walgreens Boots Alliance (WBA) and UnitedHealth Group (UNH) also utilize similar compensation strategies for their directors.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding director compensation and ownership.

Key Dates